Bennett MC, Diamond DM, Stryker SL, Parks JK, Parker WD Jr (1992) Cytochrome oxidase
inhibition: a novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol 5:
93–101
Bennett MC, Mlady GW, Kwon Y-H, Rose GM (1996a) Chronic in vivo sodium azide infusion
induces selective and stable inhibition of cytochrome c oxidase. J Neurochem 66: 2606–2611
Bennett MC, Mlady GW, Fleshner M, Rose GM (1996b) Synergy between chronic corticosterone
and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome
oxidase activity. Proc Natl Acad Sci USA 93: 1330–1334
Bennett SAL, Pappas BA, Stevens WD, Davidson CM, Fortin T, Chen J (2000) Cleavage of
amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiol Aging 21:
207–214
Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in
rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44: 491–494
Bonavita E (1986) Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile
brain. Int J Clin Pharmacol Ther Toxicol 24: 511–516
Braak H, Del Tredici K, Schultz C, Braak E (2000) Vulnerability of select neuronal types to
Alzheimer's disease. Ann NY Acad Sci 924: 53–61
Carter J, Lippa CF (2001) Beta-amyloid, neuronal death and Alzheimer's disease. Curr Mol Med
1: 733–737
Chanvitayapongs S, Draczynska-Lusiak B, Sun AY (1997) Amelioration of oxidative stress by
antioxidants and resveratrol in PC12 cells. Neuroreport 8: 1499–1502
Chen Y, Shohami E, Constantini S, Weinstock M (1998) Rivastigmine, a brain-selective
acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by
closed-head injury in the mouse. J Neurotrauma 15: 231–237
Cholerton B, Gleason CE, Baker LD, Asthana S (2002) Estrogen and Alzheimer's disease: the
story so far. Drugs Aging 19: 405–427
Colton CA, Gilbert DL (1993) Microglia, an in vivo source of reactive oxygen species in the
brain. Adv Neurol 59: 321–326
De la Torre JC, Stefano GB (2000) Evidence that Alzheimer's disease is a microvascular
disorder: the role of constitutive nitric oxide. Brain Res Rev 34: 119–136
De la Torre JC, Fortin T, Park GA, Butler KS, Kozlowski P, Pappas BA, de Socarraz H, Saunders
JK, Richard MT (1992) Chronic cerebrovascular insufficiency induces dementia-like deficits
in aged rats. Brain Res 582: 186–195
De la Torre JC, Fortin T, Park GA, Pappas BA, Richard MT (1993) Brain blood flow restoration
`rescues' chronically damaged rat CA1 neurons. Brain Res 623: 6–15
De la Torre JC, Cada A, Nelson N, Davis G, Sutherland RJ, Gonzalez-Lima F (1997) Reduced
cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats.
Neurosci Lett 223: 165–168
De Leon MJ, Harris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP (1983)
Computed tomography and positron emission transaxial tomography evaluation of normal
aging and Alzheimer's disease. J Cereb Blood Flow Metab 3: 391–394
Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer-type senile
dementia. Neurology 30: 778–782
Folli F, Bonfanti L, Renard E, Kahn CR, Merighi A (1994) Insulin receptor substrate-1 (IRS-1)
distribution in the rat central nervous system. J Neurosci 14: 6412–6422
Fr€olich F, Blum-Degen D, Hoyer S, Beckmann H, Riederer P (1998) Insulin, insulin receptors,
and Igf-I receptors in post-mortem human brain in Alzheimer's disease. In: Fisher A, Hanin I,
Yoshida M (eds) Progress in Alzheimer's and Parkinson's diseases. Plenum Press, New York
London, pp 287–293
Galani R, Obis S, Coutureau E, Jarrard L, Cassel JCA (2002) Comparison of the effects of
fimbria-fornix, hippocampal, or entorhinal cortex lesions on spatial reference and working
memory in rats: short versus long postsurgical recovery period. Neurobiol Learn Mem 77:
1–16
Gibbs R, Aggarwal P (1998) Estrogen and basal forebrain cholinergic neurons: implications for
brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 34: 98–111
